Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32615108

Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Jul
First author
Heinrich MC

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Jul;21(7):865-867. doi: 10.1016/S1470-2045(20)30335-1.
    note
    Source null
    related pmid
    32615099
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Sep;21(9):e418. doi: 10.1016/S1470-2045(20)30489-7.
    note
    Source null
    related pmid
    32888469
    relationship
    Erratum in

Authors and identifiers

  1. name
    Heinrich MC
    type
    Author
  2. name
    Jones RL
    type
    Author
  3. name
    von Mehren M
    type
    Author
  4. name
    Schöffski P
    type
    Author
  5. name
    Serrano C
    type
    Author
  6. name
    Kang YK
    type
    Author
  7. name
    Cassier PA
    type
    Author
  8. name
    Mir O
    type
    Author
  9. name
    Eskens F
    type
    Author
  10. name
    Tap WD
    type
    Author
  11. name
    Rutkowski P
    type
    Author
  12. name
    Chawla SP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Heinrich MC
    type
    Author
  2. name
    Jones RL
    type
    Author
  3. name
    von Mehren M
    type
    Author
  4. name
    Schöffski P
    type
    Author
  5. name
    Serrano C
    type
    Author
  6. name
    Kang YK
    type
    Author
  7. name
    Cassier PA
    type
    Author
  8. name
    Mir O
    type
    Author
  9. name
    Eskens F
    type
    Author
  10. name
    Tap WD
    type
    Author
  11. name
    Rutkowski P
    type
    Author
  12. name
    Chawla SP
    type
    Author
bibliography ids
  1. nci-bib-0ac36e370a2dbae35bd8d59d
book metadata
content sha256
0442cc0346d7c9382958f1a9cd7e1fb98d2a2a67ce973b157a3119d68a821e78
document type
citation
dois
  1. 10.1016/S1470-2045(20)30269-2
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32615108
immutable id
pubmed:32615108@0442cc0346d7c9382958f1a9cd7e1fb98d2a2a67ce973b157a3119d68a821e78
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
935-946
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Jul;21(7):865-867. doi: 10.1016/S1470-2045(20)30335-1.
    note
    Source null
    related pmid
    32615099
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2020 Sep;21(9):e418. doi: 10.1016/S1470-2045(20)30489-7.
    note
    Source null
    related pmid
    32888469
    relationship
    Erratum in
outcomes validated
false
pmid
32615108
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
6688d13bef5174b49abf1c98d7b62bbfce9a092e2f5685379079618367bb63e2
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Jul
precision
month
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32615108/
title
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.

Preserved source evidence · Not medical advice